3iwy
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | {{Seed}} | ||
[[Image:3iwy.png|left|200px]] | [[Image:3iwy.png|left|200px]] | ||
Line 20: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
- | + | [[3iwy]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3IWY OCA]. | |
==Reference== | ==Reference== | ||
Line 38: | Line 37: | ||
[[Category: Ubl conjugation pathway]] | [[Category: Ubl conjugation pathway]] | ||
[[Category: Zinc-finger]] | [[Category: Zinc-finger]] | ||
- | |||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Aug 12 00:06:58 2010'' |
Revision as of 03:16, 2 January 2011
Crystal structure of human MDM2 complexed with D-peptide (12 residues)
Template:ABSTRACT PUBMED 20660730
About this Structure
3iwy is a 4 chain structure. Full crystallographic information is available from OCA.
Reference
- Liu M, Li C, Pazgier M, Li C, Mao Y, Lv Y, Gu B, Wei G, Yuan W, Zhan C, Lu WY, Lu W. D-peptide inhibitors of the p53-MDM2 interaction for targeted molecular therapy of malignant neoplasms. Proc Natl Acad Sci U S A. 2010 Jul 26. PMID:20660730